Literature DB >> 31135322

Innovative Practice, Clinical Research, and the Ethical Advancement of Medicine.

Jake Earl1.   

Abstract

Innovative practice occurs when a clinician provides something new, untested, or nonstandard to a patient in the course of clinical care, rather than as part of a research study. Commentators have noted that patients engaged in innovative practice are at significant risk of suffering harm, exploitation, or autonomy violations. By creating a pathway for harmful or nonbeneficial interventions to spread within medical practice without being subjected to rigorous scientific evaluation, innovative practice poses similar risks to the wider community of patients and society as a whole. Given these concerns, how should we control and oversee innovative practice, and in particular, how should we coordinate innovative practice and clinical research? In this article, I argue that an ethical approach overseeing innovative practice must encourage the early transition to rigorous clinical research without delaying or deferring the development of beneficial innovations or violating the autonomy rights of clinicians and their patients.

Entities:  

Keywords:  clinical ethics; health regulation; medical innovation; patient rights; research ethics; standard of care

Mesh:

Year:  2019        PMID: 31135322      PMCID: PMC8778947          DOI: 10.1080/15265161.2019.1602175

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  42 in total

1.  ACOG Committee Opinion No. 352: Innovative practice: ethical guidelines.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

2.  Pay now, benefits may follow--the case of cardiac computed tomographic angiography.

Authors:  Rita F Redberg; Judith Walsh
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

Review 3.  A decade of reversal: an analysis of 146 contradicted medical practices.

Authors:  Vinay Prasad; Andrae Vandross; Caitlin Toomey; Michael Cheung; Jason Rho; Steven Quinn; Satish Jacob Chacko; Durga Borkar; Victor Gall; Senthil Selvaraj; Nancy Ho; Adam Cifu
Journal:  Mayo Clin Proc       Date:  2013-07-18       Impact factor: 7.616

4.  Access for the terminally ill to experimental medical innovations: a three-pronged threat.

Authors:  Shira Bender; Lauren Flicker; Rosamond Rhodes
Journal:  Am J Bioeth       Date:  2007-10       Impact factor: 11.229

5.  Varieties of standard-of-care treatment randomized trials: ethical implications.

Authors:  Scott Y H Kim; Franklin G Miller
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

6.  Professional and public double standards on clinical experimentation.

Authors:  I Chalmers; W A Silverman
Journal:  Control Clin Trials       Date:  1987-12

Review 7.  Medical management of stable coronary artery disease.

Authors:  Matthew Pflieger; Bradford T Winslow; Kyle Mills; Ira M Dauber
Journal:  Am Fam Physician       Date:  2011-04-01       Impact factor: 3.292

8.  Innovation in pediatric surgery: the surgical innovation continuum and the ETHICAL model.

Authors:  Jennifer A T Schwartz
Journal:  J Pediatr Surg       Date:  2013-12-21       Impact factor: 2.545

9.  Introducing new technologies: protecting subjects of surgical innovation and research.

Authors:  Martin F McKneally; Abdallah S Daar
Journal:  World J Surg       Date:  2003-06-26       Impact factor: 3.352

Review 10.  Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint.

Authors:  Joshua D Mitchell; David L Brown
Journal:  J Am Heart Assoc       Date:  2017-11-13       Impact factor: 5.501

View more
  5 in total

1.  What is a reasonable framework for new non-validated treatments?

Authors:  Gert Helgesson
Journal:  Theor Med Bioeth       Date:  2021-02-14

Review 2.  Innovative treatment as a precursor to clinical research.

Authors:  David Wendler; Seher Anjum; Peter Williamson
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

Review 3.  Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.

Authors:  Kayo Takashima; Michael Morrison; Jusaku Minari
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765

4.  Perspectives on Challenges to Cell Therapy Development in Taiwan: Strengthening Evidential Standards and Ways Forward.

Authors:  Bilikis Aderonke Abolarinwa; Malissa Kay Shaw; Chung-Hsi Lee
Journal:  Front Bioeng Biotechnol       Date:  2021-12-16

5.  'A Procedure Without a Problem', or the face transplant that didn't happen. The Royal Free, the Royal College of Surgeons and the challenge of surgical firsts.

Authors:  Fay Bound Alberti; Victoria Hoyle
Journal:  Med Humanit       Date:  2021-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.